Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of Vi-DT Typhoid Vaccine Antibodies
NCT04741828Phase 3Completed
- Sponsor
- Bio Farma
- Start
- May 2021
- Primary completion
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Typhoid conjugate vaccine Vi-DT in typhoid fever, sponsored by Bio Farma. Started May 2021; status: completed.
02
Drugs
Typhoid conjugate vaccine Vi-DT
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT04741828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04741828.